HALIFAX, NS / ACCESSWIRE / August 12, 2021 / Meta Materials Inc. (the "Company" or "META®") (NASDAQ:MMAT) a developer of high-performance functional materials and nanocomposites, today announced second quarter 2021 results. Please visit the Investors section of our website to view the Q2 2021 Shareholder Letter .
The interim financial statements and the associated management discussion and analysis for the quarter ended June 30, 2021 are available on the Investors section of our website as well as on Nasdaq.com or on the SEC EDGAR website at www.sec.gov .
In Q2 2021, total revenue grew 197%, to $624,320, compared to $210,344 in Q2 2020. For H1 2021, total revenue increased by 88%, to $1,220,623, versus $650,683 in H1 2020. The Q2 2021 net loss was $5,181,392, 3c per share on 197,911,144 weighted average shares, compared to a net loss of $1,816,741, 1c per share on 155,931,625 weighted average shares in Q2 2020. For H1 2021, the net loss was $49,339,912, 27c per share on 183,485,933 weighted average shares, compared to a loss of $3,234,029, 3c per share on 120,093,443 weighted average shares in H1 2020.
The H1 2021 net loss included a one-time, non-cash loss of $40,540,091 on financial instruments. Net cash used in operating activities during H1 2021 was $5,607,851, compared to $4,461,287 in H1 2020. Capital expenditures for purchases of property, plant, and equipment and intangible assets totaled $3,314,875. As of June 30, 2021, cash and cash equivalents totaled $154,634,423, and common shares outstanding were 279,782,854.
About Meta Materials Inc.
META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Our achievements have been widely recognized, including being named a Global Cleantech 100 company. Learn more at www.metamaterial.com .
META MATERIALS INC. | ||||||||
| As of June 30, 2021 | As of December 31, 2020 | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 154,634,423 | $ | 1,395,683 | ||||
Restricted cash | 433,627 | - | ||||||
Grants receivable | 407,523 | 327,868 | ||||||
Accounts receivable | 207,760 | 22,833 | ||||||
Inventory | 368,293 | 463,382 | ||||||
Prepaid expenses and other current assets | 1,604,710 | 514,204 | ||||||
Assets held for sale | 72,797,392 | - | ||||||
Due from related parties | 57,658 | - | ||||||
Total current assets | 230,511,386 | 2,723,970 | ||||||
Intangible assets, net | 4,389,607 | 4,476,614 | ||||||
Property, plant and equipment, net | 5,382,196 | 2,761,171 | ||||||
Operating lease right-of-use assets | 2,994,424 | 270,581 | ||||||
Goodwill | 217,613,966 | - | ||||||
Total assets | $ | 460,891,579 | $ | 10,232,336 | ||||
Liabilities and stockholders' equity (deficit) | ||||||||
Current liabilities | ||||||||
Trade and other payables | 5,377,375 | 2,940,452 | ||||||
Due to related party | - | 245,467 | ||||||
Current portion of long-term debt | 1,349,274 | 290,544 | ||||||
Current portion of deferred revenue | 1,453,556 | 1,239,927 | ||||||
Current portion of deferred government assistance | 866,011 | 779,578 | ||||||
Preferred stock liability | 77,906,354 | |||||||
Current portion of operating lease liabilities | 279,832 | 150,802 | ||||||
Asset retirement obligations | 21,937 | |||||||
Unsecured convertible promissory notes | - | 1,203,235 | ||||||
Secured convertible debentures | - | 5,545,470 | ||||||
Total current liabilities | 87,254,339 | 12,395,475 | ||||||
Deferred revenue | 681,625 | 804,143 | ||||||
Deferred government assistance | 76,807 | 146,510 | ||||||
Deferred tax liability | 219,962 | 318,054 | ||||||
Unsecured convertible debentures | - | 1,825,389 | ||||||
Long-term operating lease liabilities | 1,145,049 | 119,779 | ||||||
Funding obligation | 859,828 | 776,884 | ||||||
Long-term debt | 2,739,620 | 2,743,504 | ||||||
Total liabilities | 92,977,230 | 19,129,738 | ||||||
Stockholders' equity (deficit) | ||||||||
Common stock - $0.001 par value; 1,000,000,000 shares authorized, 279,782,854 shares issued and outstanding at June 30, 2021, and $Nil par value; unlimited shares authorized, 154,236,692 shares issued and outstanding at December 31, 2020 | 257,966 | 132,347 | ||||||
Additional paid-in capital | 454,259,192 | 29,021,974 | ||||||
Accumulated other comprehensive income (loss) | 133,946 | (654,880 | ) | |||||
Accumulated deficit | (86,736,755 | ) | (37,396,843 | ) | ||||
Total stockholders' equity (deficit) | 367,914,349 | (8,897,402 | ) | |||||
Total liabilities and stockholders' equity (deficit) | $ | 460,891,579 | $ | 10,232,336 | ||||
META MATERIALS INC. | ||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
Revenue | ||||||||||||||||
Product sales | 1,953 | - | 24,000 | 1,922 | ||||||||||||
Development revenue | 622,367 | 210,344 | 1,196,623 | 648,761 | ||||||||||||
Total Revenue | 624,320 | 210,344 | 1,220,623 | 650,683 | ||||||||||||
Cost of goods sold | 706 | 1,336 | 1,106 | 2,160 | ||||||||||||
Gross Profit | 623,614 | 209,008 | 1,219,517 | 648,523 | ||||||||||||
Operating Expenses | ||||||||||||||||
Selling & Marketing | 298,871 | 153,962 | 695,465 | 324,528 | ||||||||||||
General & Administrative | 3,145,367 | 1,553,118 | 5,738,252 | 3,157,652 | ||||||||||||
Research & Development | 1,633,653 | 960,430 | 3,412,909 | 1,892,601 | ||||||||||||
Total operating expenses | 5,077,891 | 2,667,510 | 9,846,626 | 5,374,781 | ||||||||||||
Other income (expense) | ||||||||||||||||
Interest expense, net | (427,809 | ) | (324,421 | ) | (878,717 | ) | (516,225 | ) | ||||||||
(Loss) Gain on foreign exchange, net | (163,941 | ) | (323,172 | ) | (330,385 | ) | 256,673 | |||||||||
(Loss) Gain on financial instruments, net | (535,170 | ) | 1,042,928 | (40,540,091 | ) | 1,285,765 | ||||||||||
Other income, net | 341,958 | 236,001 | 933,864 | 411,669 | ||||||||||||
Total other income (expenses) | (784,962 | ) | 631,336 | (40,815,329 | ) | 1,437,882 | ||||||||||
Loss before income taxes | (5,239,239 | ) | (1,827,166 | ) | (49,442,438 | ) | (3,288,376 | ) | ||||||||
Income tax recovery | 57,847 | 10,425 | 102,526 | 54,347 | ||||||||||||
Net loss | (5,181,392 | ) | (1,816,741 | ) | (49,339,912 | ) | (3,234,029 | ) | ||||||||
Other Comprehensive Income (Loss) net of tax | ||||||||||||||||
Foreign currency translation gain (loss) | 87,087 | 160,012 | 108,648 | (159,248 | ) | |||||||||||
Fair value gain (loss) on changes of own credit risk | 9,011 | (388,332 | ) | 680,178 | (365,208 | ) | ||||||||||
Total Other Comprehensive Income (Loss) | 96,098 | (228,320 | ) | 788,826 | (524,456 | ) | ||||||||||
Comprehensive loss | (5,085,294 | ) | (2,045,061 | ) | (48,551,086 | ) | (3,758,485 | ) | ||||||||
Basic and diluted loss per share | (0.03 | ) | (0.01 | ) | (0.27 | ) | (0.03 | ) | ||||||||
Weighted average number of shares outstanding - basic and diluted | 197,911,144 | 155,931,625 | 183,485,933 | 120,093,443 | ||||||||||||
META MATERIALS INC. CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) | ||||||||
| Six months ended | ||||||||
| June 30, 2021 | June 30, 2020 | |||||||
| $ | $ | |||||||
Cash flows from operating activities: | ||||||||
Net loss | (49,339,912 | ) | (3,234,029 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Non-cash finance income | - | (14,002 | ) | |||||
Non-cash interest expense | 742,174 | 378,485 | ||||||
Non-cash lease expense | 160,437 | - | ||||||
Deferred income tax | (102,526 | ) | (54,347 | ) | ||||
Depreciation and amortization | 1,173,884 | 1,197,123 | ||||||
Unrealized foreign currency exchange loss (gain) | 230,837 | (304,973 | ) | |||||
Loss (gain) on financial instruments, net | 40,540,091 | (1,285,765 | ) | |||||
Change in deferred revenue | 18,302 | (232,986 | ) | |||||
Non-cash government assistance | (472,499 | ) | (182,664 | ) | ||||
Loss on debt settlement | 19,253 | - | ||||||
Stock-based compensation | 651,718 | 708,468 | ||||||
Non-cash consulting expense | 12,009 | 43,673 | ||||||
Changes in operating assets and liabilities | 758,381 | (1,480,270 | ) | |||||
Net cash used in operating activities | (5,607,851 | ) | (4,461,287 | ) | ||||
Cash flows from investing activities | ||||||||
Purchases of intangible assets | (274,579 | ) | (46,977 | ) | ||||
Purchases of property, plant and equipment | (3,040,296 | ) | (538,893 | ) | ||||
Proceeds from reverse takeover | 146,954,733 | 3,072,136 | ||||||
Net cash provided by investing activities | 143,639,858 | 2,486,266 | ||||||
Cash flows from financing activities | ||||||||
Proceeds from long-term debt | 1,127,151 | 25,783 | ||||||
Repayments of long-term debt | (53,331 | ) | (190,633 | ) | ||||
Proceeds from government grants | 223,384 | 198,286 | ||||||
Proceeds from unsecured promissory notes | 13,963,386 | - | ||||||
Proceeds from secured convertible debentures | - | 3,630,019 | ||||||
Proceeds from unsecured convertible debentures | - | 693,784 | ||||||
Proceeds from issuance of common stock and warrants, net | - | 598,546 | ||||||
Proceeds from stock option exercises | 113,155 | - | ||||||
Proceeds from warrants exercises | 93,993 | - | ||||||
Proceeds from broker warrants exercises | 16,255 | - | ||||||
Net cash provided by financing activities | 15,483,993 | 4,955,785 | ||||||
Net increase in cash, cash equivalents and restricted cash | 153,516,000 | 2,980,764 | ||||||
Cash, cash equivalents and restricted cash at beginning of the period | 1,395,683 | 407,061 | ||||||
Effects of exchange rate changes on cash, cash equivalents and restricted cash | 156,367 | 3,931 | ||||||
Cash, cash equivalents and restricted cash at end of the period | 155,068,050 | 3,391,756 | ||||||
Supplemental cash flow information | ||||||||
Accrued purchases of property, equipment, and patents | 297,345 | 35,724 | ||||||
Right-of-use assets obtained in exchange for lease liabilities | 1,730,743 | - | ||||||
Right-of-use assets and prepaid expenses recognized in exchange for common stock | 2,149,381 | - | ||||||
Settlement of liabilities in common stock | 52,063,432 | - | ||||||
Interest paid on debt | 64,528 | 18,124 | ||||||
Forward Looking Information
This press release includes forward-looking information or statements within the meaning of Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, regarding the Company, Nanotech, their businesses and the proposed transaction, which may include, but are not limited to, statements with respect to the business strategies, product development, expansion plans and operational activities of the Company and Nanotech, and the benefits to the Company of the potential acquisition of Nanotech. Often but not always, forward-looking information can be identified by the use of words such as "potential," "predicts," "projects," "seeks," "plans," "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or statements that certain actions, events or results "may", "could", "should," "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management of the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks related to the potential benefits of the transaction with Nanotech, the capabilities of Nanotech's facility and the expansion thereof, research and development projects of the Company, the market potential of the products of the Company and Nanotech, the market position of the Company, the completion of the transaction, the scalability of the Company's production ability, capacity for new customer engagements, material selection programs timeframes, the ability to reduce production costs, enhance metamaterials manufacturing capabilities and extend market reach into new applications and industries, the ability to accelerate commercialization plans, the possibility of new customer contracts, the continued engagement of Nanotech's team, the technology industry, market strategic and operational activities, and management's ability to manage and to operate the business. More details about these and other risks that may impact the Company's businesses are described under the heading "Forward Looking Information" in the Company's Form 8-K filed with the SEC on July 23, 2021, and under the heading "Risk Factors" in the Company's Form 10-Q filed with the SEC on May 14, 2021, in the Company's Form 10-K filed with the SEC on March 18, 2021, and in subsequent filings made by Meta Materials with the SEC, which are available on SEC's website at www.sec.gov. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward looking statement, whether as a result of new information, future events, or otherwise, except to the extent required by law.
Contact
Mark Komonoski
Senior Vice President
Integrous Communications
Phone: 1-877-255-8483
Email: [email protected]
Media inquiries:
SOURCE: Meta Materials Inc.